Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02446769 · ClinicalTrials.gov registry record · NA
A Pilot Study to Assess the Effects of a Novel Application of Averaged Volume Assured Pressure Support Ventilation (AVAPS-AE) Therapy on Re-hospitalization in Patients With Sleep-Disordered Breathing With Co-morbid COPD
A NA study, sponsored by Philips Respironics.
- Terminated
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT02446769 is a NA study that was terminated before completion, run by Philips Respironics. The registered enrollment target is 18 participants.
The verdict
NCT02446769, a NA study, was terminated before completion, sponsored by Philips Respironics.
- TERMINATED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
This is a multicenter, randomized, parallel-group, open label study of the efficacy of AVAPS-AE to prevent re-hospitalization in hospitalized patients with comorbid Chronic Obstructive Pulmonary Disease (COPD).
Interventions
- DEVICE AVAPS-AE Non-invasive ventilation therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2017-10-06 |
| Est. Completion | 2018-05-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02446769
The ClinicalTrials.gov registry entry for NCT02446769 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Philips Respironics, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which AVAPS-AE Non-invasive ventilation therapy is the first listed.
NCT02446769 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02446769 about?
NCT02446769 is a clinical study titled "A Pilot Study to Assess the Effects of a Novel Application of Averaged Volume Assured Pressure Support Ventilation (AVAPS-AE) Therapy on Re-hospitalization in Patients With Sleep-Disordered Breathing With Co-morbid COPD". This is a multicenter, randomized, parallel-group, open label study of the efficacy of AVAPS-AE to prevent re-hospitalization in hospitalized patients with comorbid Chronic Obstructive Pulmonary Disease (COPD).
What is the current status of trial NCT02446769?
This trial is currently terminated. It is a NA study. The enrollment target is 18 participants. The study started on 2017-10-06. Estimated completion is 2018-05-21.
What interventions are being tested in trial NCT02446769?
The interventions under investigation include: AVAPS-AE Non-invasive ventilation therapy (DEVICE).
Who is sponsoring clinical trial NCT02446769?
This trial is sponsored by Philips Respironics, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.